Navigation Links
Boy Refused Compensation For HIV Infection Following Hospital Admission

The case lodged by a 9-year-old Chinese boy against a local health agency for infecting him with HIV virus has ended up in favor of the health concern // , much to the disappointment of the applicant and his family members.

The boy is said to have contracted the virus following a post-operative blood transfusion, in a Beijing hospital (Stomatological Hospital). Red Cross blood center is believed to have provided the infected blood product. Both parents have been found to have a negative infection status, highlighting the possibility of HIV transmission through blood transfusion.

Authorities, owing to lack of proper available proof regarding the issue have turned down the case. The victim’s parents had claimed a compensation for the mental trauma and other forms of medical expenses incurred.

A case filed earlier by the child turned out to be unsuccessful following refusal of the blood center to submit the medical records for verification, in an effort to retain confidentiality of the medical record.

The positive infection status was identified in November 2003, when the boy underwent blood tests for diagnosis of his pneumonia infection. The only possible source of infection was identified as a blood transfusion (August 2002) following surgical repair of the boy’s cleft palate, a developmental abnormality associated with the face.

The director of the hospital however dismissed the blame, stating that the boy's HIV infection was not connected to the hospital. Furthermore, she said that the boy could have contracted the virus elsewhere as he had been operated in other hospitals in Henan province previously.

There has been an increase in the number of lawsuits against numerous health agencies in China over HIV-tainted blood in recent years. Contrary to the above case, the applicants infected with the HIV virus have received financial compensation in numerous instances. The number of HIV-inf ected people in China is believed to be over 1 million, although the actual figure is likely to be much higher.


'"/>




Related medicine news :

1. Smoker Refused Treatment
2. One in Ten NHS Dentists Refused To Sign the New Contract
3. Drug Refused to Asbestos-Linked Cancer Patients
4. Gardasil Refused Subsidy
5. NRI Fights for HIV Child Who was Refused Treatment
6. Organ Scandals Compensation And The Aftermath
7. Mother Claims Hefty Compensation For Failed Abortion Of Twins
8. Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong
9. Stage Set For Final Hearing On India’s Biggest Ever Medical Compensation Clai
10. Extend Workers Compensation To Firefighters. Pleads Son
11. £300,000 Compensation For Family After Death Of Daughter Following Deliver
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: